## Abstract Familial risk of pancreatic cancer has been mainly assessed through case‐control studies based on reported but not medically verified cancers in family members. We used the nationwide Swedish Family‐Cancer Database on 10.2 million individuals and 21,000 pancreatic cancers to calculate s
Familial and second gastric carcinomas : A nationwide epidemiologic study from Sweden
✍ Scribed by Kari Hemminki; Yongwen Jiang
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 88 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Familial risks in patients with breast carcinoma have not been assessed by morphologic types of medically verified cancers. Reliable data on familial risks would help to establish prevention programs and guide clinical decisions. ## METHODS We used the nationwide Swedis
## Abstract A few case‐control studies have been published on familial risks in esophageal cancer. Reliable data on familial risks are needed for prevention and clinical decisions. We used the nation‐wide Swedish Family‐Cancer Database on 10.1 million individuals and close to 6000 esophageal cancer
## Abstract Population attributable factions (PAFs) show the proportion of the disease that could be prevented if the cause could be removed. The PAF for familial breast cancer has not been precisely determined. We used the nationwide Swedish Family‐Cancer Database on 10.2 million individuals and 1
Carcinoids are rare neuroendocrine tumors, mainly located in the bowel, stomach and lung. Familial risks in carcinoid tumours are not well known apart from multiple endocrine neoplasia 1 (MEN1). We used the nation-wide Swedish Family-Cancer Database on 10.1 million individuals for assessment. Carcin